(Circulation. 1995;91:284-290.)
© 1995 American Heart Association, Inc.
Articles |
Association of Fibrinolytic Parameters With Early Atherosclerosis
The ARIC Study
From the Department of Epidemiology and Health Promotion (V. Salomaa), National Public Health Institute, Helsinki, Finland; Division of Hematology (V. Stinson, K.K.W.), University of Texas (Houston); Hadassah School of Public Health (J.D.K.), Hebrew University, Jerusalem, Israel; Division of Epidemiology (A.R.F.), School of Public Health, University of Minnesota (Minneapolis); and Collaborative Studies Coordinating Center (C.E.D.), Department of Biostatistics, University of North Carolina at Chapel Hill.
Correspondence to Kenneth K. Wu, MD, Professor and Director, Division of Hematology, University of Texas Medical School at Houston, 6431 Fannin, MSB 5.016, Houston, TX 77030.
Background Thrombosis, provoked by a rupture of an atherosclerotic plaque, plays a crucial role in precipitating a coronary heart disease event. Its role at the early stage of atherosclerosis has, however, been unclear, but it has been hypothesized that thrombosis or defective fibrinolysis contributes to the progression of atherosclerotic lesions.
Methods and Results We studied the association of plasminogen
activator inhibitor antigen (PAI-1), tissue-type plasminogen activator
antigen (TPA), and D-dimer with early atherosclerosis in a
cross-sectional case-control study involving 457 pairs chosen from the
biracial cohort of the Atherosclerosis Risk in Communities (ARIC)
Study. As examined by B-mode ultrasound, patients (cases) had
intima-media thickness of carotid arteries above the 90th percentile
and control subjects had thickness below the 75th percentile of the
ARIC cohort. Persons with a history of heart disease, stroke, or
claudication were excluded from the case-control selection. PAI-1, TPA,
and D-dimer were higher in patients than in control subjects
(P
.001, Wilcoxon signed rank statistic). In conditional
logistic regression analyses, the odds ratios of carotid
atherosclerosis were, for PAI-1, for example, 1.22, 1.54, and 1.60 in
the second, third, and fourth quartiles compared with the first
quartile (P<.0001, test of linear trend, adjusting for age,
systolic blood pressure, total cholesterol, acetylsalicylic acid use,
and time of blood draw). Corresponding tests for D-dimer and TPA also
showed an increasing trend (P<.0001).
Conclusions The findings support the hypothesis that thrombosis and fibrinolysis play a role at the early stage of the atherosclerotic process.
Key Words: thrombosis • blood cells • coagulation • atherosclerosis
This article has been cited by other articles:
 |
|
 |
|
  W. Lieb, M. G. Larson, E. J. Benjamin, X. Yin, G. H. Tofler, J. Selhub, P. F. Jacques, T. J. Wang, J. A. Vita, D. Levy, et al. Multimarker Approach to Evaluate Correlates of Vascular Stiffness: The Framingham Heart Study Circulation, January 6, 2009; 119(1): 37 - 43. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-C. Liao, H.-F. Lin, T. Rundek, R. Cheng, Y.-C. Guo, R. L. Sacco, and S.-H. H. Juo Segment-Specific Genetic Effects on Carotid Intima-Media Thickness: The Northern Manhattan Study Stroke, December 1, 2008; 39(12): 3159 - 3165. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Demyanets, C. Kaun, K. Rychli, G. Rega, S. Pfaffenberger, T. Afonyushkin, V. N. Bochkov, G. Maurer, K. Huber, and J. Wojta The inflammatory cytokine oncostatin M induces PAI-1 in human vascular smooth muscle cells in vitro via PI 3-kinase and ERK1/2-dependent pathways Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1962 - H1968. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Crouse III Thematic review series: Patient-Oriented Research. Imaging atherosclerosis: state of the art J. Lipid Res., August 1, 2006; 47(8): 1677 - 1699. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Tzoulaki, G. D. Murray, J. F. Price, F. B. Smith, A. J. Lee, A. Rumley, G. D. O. Lowe, and F. G. R. Fowkes Hemostatic Factors, Inflammatory Markers, and Progressive Peripheral Atherosclerosis: The Edinburgh Artery Study Am. J. Epidemiol., February 15, 2006; 163(4): 334 - 341. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. M. Szymanski, C. M. Kessler, and B. Fernhall Relationship of physical fitness, hormone replacement therapy, and hemostatic risk factors in postmenopausal women J Appl Physiol, April 1, 2005; 98(4): 1341 - 1348. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E.-G. V. Giardina, H. J. Chen, R. R. Sciacca, and L. E. Rabbani Dynamic Variability of Hemostatic and Fibrinolytic Factors in Young Women J. Clin. Endocrinol. Metab., December 1, 2004; 89(12): 6179 - 6184. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Vadseth, J. M. Souza, L. Thomson, A. Seagraves, C. Nagaswami, T. Scheiner, J. Torbet, G. Vilaire, J. S. Bennett, J.-C. Murciano, et al. Pro-thrombotic State Induced by Post-translational Modification of Fibrinogen by Reactive Nitrogen Species J. Biol. Chem., March 5, 2004; 279(10): 8820 - 8826. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G.D.O. Lowe, J. Danesh, S. Lewington, M. Walker, L. Lennon, A. Thomson, A. Rumley, and P.H. Whincup Tissue plasminogen activator antigen and coronary heart disease: Prospective study and meta-analysis Eur. Heart J., February 1, 2004; 25(3): 252 - 259. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Muller, A. S. Lindman, A. Blomfeldt, I. Seljeflot, and J. I. Pedersen A Diet Rich in Coconut Oil Reduces Diurnal Postprandial Variations in Circulating Tissue Plasminogen Activator Antigen and Fasting Lipoprotein (a) Compared with a Diet Rich in Unsaturated Fat in Women J. Nutr., November 1, 2003; 133(11): 3422 - 3427. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Luttun, F. Lupu, E. Storkebaum, M. F. Hoylaerts, L. Moons, J. Crawley, F. Bono, A. R. Poole, P. Tipping, J.-M. Herbert, et al. Lack of Plasminogen Activator Inhibitor-1 Promotes Growth and Abnormal Matrix Remodeling of Advanced Atherosclerotic Plaques in Apolipoprotein E-Deficient Mice Arterioscler Thromb Vasc Biol, March 1, 2002; 22(3): 499 - 505. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Badimon, G. Vilahur, S. Sanchez, and X. Duran Atheromatous plaque formation and thrombogenesis: formation, risk factors and therapeutic approaches Eur. Heart J. Suppl., August 1, 2001; 3(suppl_I): I16 - I22. [Abstract] [PDF]
|
|
|
|
|
|
A. R. Folsom, N. Aleksic, E. Park, V. Salomaa, H. Juneja, and K. K. Wu Prospective Study of Fibrinolytic Factors and Incident Coronary Heart Disease : The Atherosclerosis Risk in Communities (ARIC) Study Arterioscler Thromb Vasc Biol, April 1, 2001; 21(4): 611 - 617. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Kario, T. Matsuo, H. Kobayashi, S. Hoshide, and K. Shimada Hyperinsulinemia and hemostatic abnormalities are associated with silent lacunar cerebral infarcts in elderly hypertensive subjects J. Am. Coll. Cardiol., March 1, 2001; 37(3): 871 - 877. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Orbe, J. A Rodriguez, A. Calvo, A. Grau, M. S Belzunce, D. Martinez-Caro, and J. A Paramo Vitamins C and E attenuate plasminogen activator inhibitor-1 (PAI-1) expression in a hypercholesterolemic porcine model of angioplasty Cardiovasc Res, February 1, 2001; 49(2): 484 - 492. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Cote, C. Wolfson, S. Solymoss, A. Mackey, J. R Leclerc, D. Simard, F. Rouah, F. Bourque, and B. Leger Hemostatic Markers in Patients at Risk of Cerebral Ischemia Stroke, August 1, 2000; 31(8): 1856 - 1862. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Collet, D. Park, C. Lesty, J. Soria, C. Soria, G. Montalescot, and J. W. Weisel Influence of Fibrin Network Conformation and Fibrin Fiber Diameter on Fibrinolysis Speed : Dynamic and Structural Approaches by Confocal Microscopy Arterioscler Thromb Vasc Biol, May 1, 2000; 20(5): 1354 - 1361. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. B. Meigs, M. A. Mittleman, D. M. Nathan, G. H. Tofler, D. E. Singer, P. M. Murphy-Sheehy, I. Lipinska, R. B. D'Agostino, and P. W. F. Wilson Hyperinsulinemia, Hyperglycemia, and Impaired Hemostasis: The Framingham Offspring Study JAMA, January 12, 2000; 283(2): 221 - 228. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Johansson, J.-H. Jansson, K. Boman, T. K. Nilsson, B. Stegmayr, and G. Hallmans Tissue Plasminogen Activator, Plasminogen Activator Inhibitor-1, and Tissue Plasminogen Activator/Plasminogen Activator Inhibitor-1 Complex as Risk Factors for the Development of a First Stroke Stroke, January 1, 2000; 31(1): 26 - 32. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-C. Tataru, J. Heinrich, R. Junker, H. Schulte, A. von Eckardstein, G. Assmann, and E. Koehler D-dimers in relation to the severity of arteriosclerosis in patients with stable angina pectoris after myocardial infarction Eur. Heart J., October 2, 1999; 20(20): 1493 - 1502. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Nauck, H. Wieland, and W. Marz Rapid, Homogeneous Genotyping of the 4G/5G Polymorphism in the Promoter Region of the PAI1 Gene by Fluorescence Resonance Energy Transfer and Probe Melting Curves Clin. Chem., August 1, 1999; 45(8): 1141 - 1147. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Cesari and G. P. Rossi Plasminogen Activator Inhibitor Type 1 in Ischemic Cardiomyopathy Arterioscler Thromb Vasc Biol, June 1, 1999; 19(6): 1378 - 1386. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Pahor, M. B. Elam, R. J. Garrison, S. B. Kritchevsky, and W. B. Applegate Emerging Noninvasive Biochemical Measures to Predict Cardiovascular Risk Arch Intern Med, February 8, 1999; 159(3): 237 - 245. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Q. Callister, P. Raggi, B. Cooil, N. J. Lippolis, and D. J. Russo Effect of HMG-CoA Reductase Inhibitors on Coronary Artery Disease as Assessed by Electron-Beam Computed Tomography N. Engl. J. Med., December 31, 1998; 339(27): 1972 - 1978. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Geppert, S. Graf, R. Beckmann, S. Hornykewycz, E. Schuster, B. R. Binder, and K. Huber Concentration of Endogenous tPA Antigen in Coronary Artery Disease : Relation to Thrombotic Events, Aspirin Treatment, Hyperlipidemia, and Multivessel Disease Arterioscler Thromb Vasc Biol, October 1, 1998; 18(10): 1634 - 1642. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. W. Courtman, S. M. Schwartz, and C. E. Hart Sequential Injury of the Rabbit Abdominal Aorta Induces Intramural Coagulation and Luminal Narrowing Independent of Intimal Mass : Extrinsic Pathway Inhibition Eliminates Luminal Narrowing Circ. Res., May 19, 1998; 82(9): 996 - 1006. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Lee, P. I. Mowbray, G. D.O. Lowe, A. Rumley, F. G. R. Fowkes, and P. L. Allan Blood Viscosity and Elevated Carotid Intima-Media Thickness in Men and Women : The Edinburgh Artery Study Circulation, April 21, 1998; 97(15): 1467 - 1473. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. DeSouza, P. P. Jones, and D. R. Seals Physical Activity Status and Adverse Age-Related Differences in Coagulation and Fibrinolytic Factors in Women Arterioscler Thromb Vasc Biol, March 1, 1998; 18(3): 362 - 368. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Schmidt, R. Schmidt, K. Niederkorn, S. Horner, P. Becsagh, B. Reinhart, M. Schumacher, V. Weinrauch, and G. M. Kostner ß-Fibrinogen Gene Polymorphism (C148->T) Is Associated With Carotid Atherosclerosis : Results of the Austrian Stroke Prevention Study Arterioscler Thromb Vasc Biol, March 1, 1998; 18(3): 487 - 492. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Henry, D.A. Tregouet, M.C. Alessi, M.F. Aillaud, S. Visvikis, G. Siest, L. Tiret, and I. Juhan-Vague Metabolic Determinants Are Much More Important Than Genetic Polymorphisms in Determining the PAI-1 Activity and Antigen Plasma Concentrations : A Family Study With Part of the Stanislas Cohort Arterioscler Thromb Vasc Biol, January 1, 1998; 18(1): 84 - 91. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Tomiyama, Y. Kimura, H. Mitsuhashi, T. Kinouchi, H. Yoshida, T. Kushiro, and N. Doba Relationship Between Endothelial Function and Fibrinolysis in Early Hypertension Hypertension, January 1, 1998; 31(1): 321 - 327. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Schneider, M. A. Ricci, D. J. Taatjes, P. Q. Baumann, J. C. Reese, B. J. Leavitt, P. M. Absher, and B. E. Sobel Changes in Arterial Expression of Fibrinolytic System Proteins in Atherogenesis Arterioscler Thromb Vasc Biol, November 1, 1997; 17(11): 3294 - 3301. [Abstract] [Full Text]
|
|
|
|
|
|
P. W.F. Wilson, J. M. Hoeg, R. B. D'Agostino, H. Silbershatz, A. M. Belanger, H. Poehlmann, D. O'Leary, and P. A. Wolf Cumulative Effects of High Cholesterol Levels, High Blood Pressure, and Cigarette Smoking on Carotid Stenosis N. Engl. J. Med., August 21, 1997; 337(8): 516 - 522. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Fernhall, L. M. Szymanski, P. A. Gorman, J. Milani, D. C. Paup, and C. M. Kessler Fibrinolytic Activity Is Similar in Physically Active Men With and Without a History of Myocardial Infarction Arterioscler Thromb Vasc Biol, June 1, 1997; 17(6): 1106 - 1113. [Abstract] [Full Text]
|
|
|
|
|
|
M. Henry, N. Chomiki, P. Y. Scarabin, M. C. Alessi, F. Peiretti, D. Arveiler, J. Ferrieres, A. Evans, P. Amouyel, O. Poirier, et al. Five Frequent Polymorphisms of the PAI-1 Gene: Lack of Association Between Genotypes, PAI Activity, and Triglyceride Levels in a Healthy Population Arterioscler Thromb Vasc Biol, May 1, 1997; 17(5): 851 - 858. [Abstract] [Full Text]
|
|
|
|
|
|
G. Christ, P. Hufnagl, C. Kaun, G. Mundigler, G. Laufer, K. Huber, J. Wojta, and B. R. Binder Antifibrinolytic Properties of the Vascular Wall: Dependence on the History of Smooth Muscle Cell Doublings In Vitro and In Vivo Arterioscler Thromb Vasc Biol, April 1, 1997; 17(4): 723 - 730. [Abstract] [Full Text]
|
|
|
|
|
|
K. K. Koh, R. Mincemoyer, M. N. Bui, G. Csako, F. Pucino, V. Guetta, M. Waclawiw, and R. O. Cannon Effects of Hormone-Replacement Therapy on Fibrinolysis in Postmenopausal Women N. Engl. J. Med., March 6, 1997; 336(10): 683 - 691. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.-H. Pan, C.-H. Bai, J.-R. Chen, and H.-C. Chiu Associations Between Carotid Atherosclerosis and High Factor VIII Activity, Dyslipidemia, and Hypertension Stroke, January 1, 1997; 28(1): 88 - 94. [Abstract] [Full Text]
|
|
|
|
|
|
H. R. Lijnen and D. Collen Impaired Fibrinolysis and the Risk for Coronary Heart Disease Circulation, November 1, 1996; 94(9): 2052 - 2054. [Full Text]
|
|
|
|
|
|
E. Shahar, A. R. Folsom, V. V. Salomaa, V. L. Stinson, P. G. McGovern, T. Shimakawa, L. E. Chambless, and K. K. Wu Relation of Hormone-Replacement Therapy to Measures of Plasma Fibrinolytic Activity Circulation, June 1, 1996; 93(11): 1970 - 1975. [Abstract] [Full Text]
|
|
|
|
|
|
C. H. Lundgren, S. L. Brown, T. K. Nordt, B. E. Sobel, and S. Fujii Elaboration of Type-1 Plasminogen Activator Inhibitor From Adipocytes : A Potential Pathogenetic Link Between Obesity and Cardiovascular Disease Circulation, January 1, 1996; 93(1): 106 - 110. [Abstract] [Full Text]
|
|
|
|
|
|
H. R. Lijnen, B. Arza, B. Van Hoef, D. Collen, and P. J. Declerck Inactivation of Plasminogen Activator Inhibitor-1 by Specific Proteolysis with Stromelysin-1 (MMP-3) J. Biol. Chem., November 22, 2000; 275(48): 37645 - 37650. [Abstract] [Full Text] [PDF]
|
|